Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine if Oxalobacter formigenes is effective at
lowering urinary oxalate levels in patients with primary hyperoxaluria.